• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Materials (March 18, 2009: Circulatory System Devices Panel Meeting)

FDA Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA
and FDA does not necessarily agree with the sponsor's statements. FDA has not made a
final detemlination about the safety or effectiveness of the product described in this
document.

Sponsor Disclaimer

Portions of this document have been determined to be exempt from disclosure under the
Freedom of lnfoffilation Act (the FOIA) (5 U.S.c. §552). These redacted portions will
appear as white spaces on the screen or on the printed page.